DrugPatentWatch Database Preview
Gonadotropin, chorionic - Biologic Drug Details
» See Plans and Pricing
Summary for gonadotropin, chorionic
| Tradenames: | 3 |
| Patents: | 665 |
| Applicants: | 4 |
| BLAs: | 5 |
| Suppliers: see list | 3 |
| Recent Clinical Trials: | See clinical trials for gonadotropin, chorionic |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for gonadotropin, chorionic |
Recent Clinical Trials for gonadotropin, chorionic
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Al-Azhar University | N/A |
| Beijing Cancer Hospital | Phase 2 |
| 3M | Phase 1/Phase 2 |
Recent Litigation for gonadotropin, chorionic
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Ravgen, Inc. v. Progenity, Inc. | 2020-12-20 |
| Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC | 2018-12-19 |
| Amgen Inc. v. Accord Healthcare, Inc. | 2018-06-28 |
See all gonadotropin, chorionic litigation
PTAB Litigation
| Petitioner | Date |
|---|---|
| Quest Diagnostics Incorporated | 2020-09-11 |
| 2017-01-10 | |
| 2013-07-29 |
Patent Text Search: US Patents for gonadotropin, chorionic
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring | A.P.L. | gonadotropin, chorionic | INJECTABLE;INJECTION | 017055 | 001 | 1975-06-30 | Start Trial | ASCENDIS PHARMA A/S (Hellrup, DK) | 2024-07-05 | DISCN | search | |
| Ferring | A.P.L. | gonadotropin, chorionic | INJECTABLE;INJECTION | 017055 | 001 | 1975-06-30 | Start Trial | 2040-04-01 | DISCN | search | ||
| Ferring | A.P.L. | gonadotropin, chorionic | INJECTABLE;INJECTION | 017055 | 001 | 1975-06-30 | Start Trial | 2007-01-30 | DISCN | search | ||
| Ferring | A.P.L. | gonadotropin, chorionic | INJECTABLE;INJECTION | 017055 | 001 | 1975-06-30 | Start Trial | 2007-02-06 | DISCN | search | ||
| Ferring | A.P.L. | gonadotropin, chorionic | INJECTABLE;INJECTION | 017055 | 001 | 1975-06-30 | Start Trial | Aprogenex, Inc. (Houston, TX) | 2012-07-17 | DISCN | search | |
| Ferring | A.P.L. | gonadotropin, chorionic | INJECTABLE;INJECTION | 017055 | 001 | 1975-06-30 | Start Trial | 2018-08-17 | DISCN | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for gonadotropin, chorionic
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Austria | 411340 | Start Trial |
| Poland | 217623 | Start Trial |
| Spain | 2080944 | Start Trial |
| Hungary | E027973 | Start Trial |
| Denmark | 412878 | Start Trial |
| Australia | 2004230592 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for gonadotropin, chorionic
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2010 | Austria | Start Trial | PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125 |
| 2017 00022 | Denmark | Start Trial | PRODUCT NAME: REKOMBINANT FSH (RFSH) INKLUDERENDE ALPHA2,3-SIALYLERING OG ALPHA2,6-SIALYLERING HVOR 80% ELLER MERE AF DEN TOTALE SIALYLERING ER ALPHA2,3-SIALYLERING OG HVOR FRA 5% TIL 20% AF DEN TOTALE SIALYLERING ER ALPHA2,6-SIALYLERING, SAERLIGT FOLLITROPIN DELTA; REG. NO/DATE: EU/1/16/1150/001-003 20161214 |
| C/GB01/022 | United Kingdom | Start Trial | PRODUCT NAME: RECOMBINANT HUMAN LUTEINISING HORMONE; REGISTERED: UK EU/1/00/155/001-006 20001129 |
| 2010000006 | Germany | Start Trial | PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125 |
| 90023-4 | Sweden | Start Trial | PERIOD OF VALIDITY (FROM - UNTIL): 20290417 - 20311213 |
| 2017018 | Lithuania | Start Trial | PRODUCT NAME: REKOMBINANTINIS FSH, ISKAITANT ALFA 2,3-SIALINIMA IR ALFA 2,6-SIALINIMA, KUR 80 PROCENTU ARBA DAUGIAU BENDRO SIALINIMO YRA ALFA 2,3-SIALINIMAS IR KUR NUO 5 IKI 20 PROCENTU BENDRO SIALINIMO YRA ALFA 2,6-SIALINIMAS, YPATINGAI FOLITROPINAS DELTA; REGISTRATION NO/DATE: EU/1/16/1150 20161212 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
